Marea Eyes Cardioprotective Benefit With ANGPTL4 Inhibition

 
• By Joseph Haas
  
cardiovascular system
Marea hopes ANGPTL4 inhibition can benefit high-risk cardiovascular patients • Source: Shutterstock

More from Strategy

More from R&D